Physician profile
John Waites
NPI 1326082124
$5,044.27
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $961 · 2021: $1,488 · 2022: $640 · 2023: $747 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,797.08 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $1,074.48 | 2019-2022 | |
| Pfizer INC. | $657.94 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $525.91 | 2019-2023 | Eliquis, Camzyos |
| Amgen INC. | $179.74 | 2019-2024 | Repatha |
| Tactile Systems Technology INC | $153.36 | 2019-2020 | |
| Lemaitre Vascular, INC. | $74.49 | 2022 | |
| Medtronic, INC. | $68.46 | 2021 | |
| Koya Medical, INC. | $65.28 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.05 | 2019-2020 | |
| Shockwave Medical, INC | $57.21 | 2022 | |
| Organogenesis INC. | $54.99 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $49.28 | 2022-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.77 | 2019-2023 | Lifevest |
| Portola Pharmaceuticals, LLC | $47.20 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $37.66 | 2022-2023 | Restrata Wound Matrix |
| Janssen Scientific Affairs, LLC | $34.02 | 2019-2021 | |
| Silk Road Medical, INC. | $18.73 | 2022 | |
| Lundbeck LLC | $15.69 | 2021 | |
| Atricure, INC. | $11.99 | 2020 | |
| Chiesi USA, INC. | $11.94 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Waites listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.